Dow Down 0.18% Nasdaq Up 0.39%

Mast Therapeutics, Inc. (MSTX)

-NYSE MKT
0.60 Down 0.02(3.81%) 4:02PM EDT
Prev Close:0.63
Open:0.63
Bid:0.59 x 2200
Ask:0.64 x 10000
1y Target Est:1.75
Beta:2.24
Next Earnings Date:N/A
Day's Range:0.60 - 0.64
52wk Range:0.40 - 1.10
Volume:763,115
Avg Vol (3m):883,191
Market Cap:73.13M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MSTX

Comparison

Symbol% ChgMkt Cap
MSTXDown 3.81%73.13M
GSKDown 1.65%115.99B
RHHBYUp 0.14%248.42B
SNYUp 0.49%144.25B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. It primarily develops MST-188, a phase III product candidate that has hemorheologic, cytoprotective, and anti-inflammat... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback